Healthcare RFID market seen reaching $28.44 billion by 2035

Market Research Future projects the global healthcare RFID market will rise from $6.02 billion in 2025 to $28.44 billion by 2035, driven by traceability rules, asset utilization gains and surgical tray savings. North America leads today, while Asia-Pacific is forecast to grow the fastest through 2035.

Why it matters: - Healthcare RFID is moving from a niche tracking tool to a compliance and operations platform. - The market’s growth is tied to drug serialization rules, equipment utilization gains and lower reprocessing costs in operating rooms. - Hospitals, pharmacies and logistics providers are using RFID to reduce waste, improve traceability and recover staff time.

What happened: - Market Research Future projected the global healthcare RFID market will reach $28.44 billion by 2035 from $6.02 billion in 2025. - The forecast implies a 16.8% CAGR for 2026–2035. - The first forecast year, 2026, is valued at $7.03 billion. - The report was published Sept. 10, 2026. - A free sample and detailed report are available.

The details: - Drug Supply Chain Security Act tracing requirements became fully enforceable for dispensers in November 2024 in the U.S., covering an estimated 6.1 billion prescription units annually. - Hospitals typically own 12,000 to 15,000 movable devices per 500-bed campus. - True infusion pump utilization is estimated at 32% to 38%, versus purchasing assumptions above 70%. - Duke University Health System documented a 66% reduction in tray contents after RFID-guided surgical tray rationalization. - North America held 38.5% of 2025 revenue, supported by dense capital-equipment fleets and stronger traceability rules. - Asia-Pacific is forecast as the fastest-growing region at a 19.6% CAGR. - Tags and labels were the largest component segment in 2025 with a 42.9% share. - Software and analytics is the fastest-growing component at a 19.9% CAGR. - UHF/RAIN was the largest tag frequency segment in 2025 with a 51.2% share. - Microwave tags are forecast to grow fastest at a 20.5% CAGR. - Asset tracking was the largest application segment in 2025 with a 29.5% share. - Surgical-instrument visibility is forecast to grow fastest at a 20.4% CAGR. - Hospitals were the largest end-user segment in 2025 with a 56.2% share. - Contract logistics and third-party providers are forecast to grow fastest at a 19.6% CAGR. - Zebra Technologies, Impinj, Avery Dennison, Honeywell International, HID Global, Securitas Healthcare, CenTrak, Terso Solutions, Alien Technology, Oracle and Mobile Aspects were listed among key players. - Avery Dennison expanded medical-grade inlay production capacity in September 2024 for repeated steam sterilization cycles on reusable instruments.

Between the lines: - The market case is less about hardware adoption alone and more about mandatory item-level traceability across healthcare supply chains. - The strongest near-term ROI appears in places where RFID can cut replacement spending, reduce rental costs or compress sterilization workload. - Buyers are also shifting toward software and managed services, which suggests future value will come from data interpretation and workflow redesign, not just tags and readers. - Regional growth is tilting toward countries building new hospitals or modernizing digital infrastructure from the ground up.

What's next: - The report expects new demand from autonomous inventory tools, predictive replenishment, greenfield hospital construction, subscription service models and sensor-enabled battery-free tags. - Ambulatory surgery centers and outpatient sites are also emerging as a smaller-cost deployment opportunity. - Circularity and reusable-device tracking could open another budget line tied to sustainability and reprocessing. - The market is projected to keep expanding as healthcare RFID moves from asset visibility toward closed-loop clinical and supply orchestration.

The bottom line: - Healthcare RFID is set to become a core infrastructure layer for compliance, operations and inventory control across hospitals and life sciences supply chains.